‹ All Posts
Rakesh Kumar

24th Jan · SEBI-Registered Analyst

JB CHEMICALS Results Analysis-Q3FY26

JBCHEPHARM
Operating Revenue for Q3FY26 is Rs. 1,065 Crs., 10.51% growth YoY, Total Income is Rs. 1,083 Crs., 11.48% growth YoY, EBITDA is Rs. 296 Crs., 16.23% growth YoY, EBITDA Margin is 27.78% improved by 137 Basis points YoY, PBT Rs. 267 Crs, 22.4% growth YoY, PAT Rs. 198 Crs, 21.8% growth YoY. On QoQ basis Op. Revenue is down by 1.86%, Total Income is down by 1.57%, EBITDA is down by 4.45%, PBT is down by 4.4% and PAT is also down by 4.78%. Domestic formulations business recorded revenue of Rs. 620 crores with 10% growth YoY basis. International business recorded revenue of Rs. 445 crores with 12% growth YoY basis. International formulations business grew by 20% to INR 306 crores for Q3 FY26–All the exports businesses viz. South Africa, Russia, USA and branded exports markets performed well for the quarter.

#WatchOutFor#FundamentalViews#TrendingSectors#PsychologyofMoney#MacroViews
520 likes·65 comments